close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

8.650 +0.260 (+3.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
From Bicycle Therapeutics plc
Via Business Wire
Expert Ratings For Bicycle Therapeutics
 
Via Benzinga
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
The Analyst Landscape: 4 Takes On Bicycle Therapeutics
 
Via Benzinga
Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics
 
Via Benzinga
Expert Ratings for Bicycle Therapeutics
 
Via Benzinga
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
From Bicycle Therapeutics plc
Via Business Wire
Where Bicycle Therapeutics Stands With Analysts
 
Via Benzinga
Expert Ratings for Bicycle Therapeutics
 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
From Bicycle Therapeutics plc
Via Business Wire
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
From Bicycle Therapeutics
Via Business Wire
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Bicycle Therapeutics to Host R&D Day on December 14
From Bicycle Therapeutics
Via Business Wire
9 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
From Bicycle Therapeutics
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
 
Via Benzinga
Why Shares of Bicycle Therapeutics Were Rising on Monday
The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy. 
Via The Motley Fool
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Bicycle Therapeutics plc
Via Business Wire
Why Bicycle Therapeutics Stock Raced Ahead Today
The company's latest attempt at capital raising seems to be having enviable success. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today